Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: A randomized controlled trial

Infection Control and Hospital Epidemiology

Volumn 30, Issue 10, 2009, Pages 931-938

  Camins, Bernard C ^a,e   King, Mark D ^b,e,f   Wells, Jane B ^c,g   Googe, Heidi L ^d,g   Patel, Manish ^g   Kourbatova, Ekaterina V ^e   Blumberg, Henry M ^e,f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Beacon Center for Infectious Diseases   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Division of Epidemiology Human Genetics Environmental Sciences   (United States)

^g GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ANTIMICROBIAL UTILIZATION TEAM; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG INDICATION; DRUG USE; FEEDBACK SYSTEM; FEMALE; HUMAN; INFECTION; INTERNAL MEDICINE; MALE; MICROBIOLOGY; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; TEAMWORK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, TEACHING; HUMANS; INTERNAL MEDICINE; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROGRAM EVALUATION; YOUNG ADULT;

EID: 70350020444     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/605924     Document Type: Article

References (27)

1. US Congress, Office of Technology Assessment. Impact of antibioticresistant bacteria (OTA-H-629), 1995.Washington, DC: US Government Printing Office, 1995.
2. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343:1917-1924.
3. Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE Jr. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis 2001; 33:324-330.
4. Fridkin SK, Hill HA, Volkova NV, et al. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002; 8: 697-701.
5. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003; 289: 885-888.
6. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337:441-446.
7. Huovinen P, Seppala H, Kataja J, Klaukka T. The relationship between erythromycin consumption and resistance in Finland. Finnish Study Group for Antimicrobial Resistance. Ciba Found Symp 1997; 207:36-41.
8. Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationshipbetween antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8:278-282.
9. Monnet DL, MacKenzie FM, Lopez-Lozano JM, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10:1432-1441.
10. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992; 257:1050-1055.
11. Forum on Emerging Infections, Institute of Medicine. Antimicrobial Resistance: Issues and Options. Washington, DC: National Academy Press, 1998.
12. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134:298-314.
13. Dunagan WC, Woodward RS, Medoff G, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med 1989; 87:253-259.
14. Arbo MD, Snydman DR. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med 1994; 154:2641-2645.
15. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997; 24:471-485.
16. Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998; 338:232-238.
17. DeLisle S, Perl TM. Antimicrobial management measures to limit resistance: a process-based conceptual framework. Crit Care Med 2001; 29: N121-N127.
18. White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25:230-239. (Pubitemid 127775484)
19. Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med 1997; 157:1689-1694.
20. Solomon DH, Van HL, Glynn RJ, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001; 161:1897-1902.
21. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001; 33:289-295.
22. Dranitsaris G, Spizzirri D, Pitre M, McGeer A. A randomized trial to measure the optimal role of the pharmacist in promoting evidencebased antibiotic use in acute care hospitals. Int J Technol Assess Health Care 2001; 17:171-180.
23. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25:584-599.
24. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234-240.
25. Bantar C, Sartori B, Vesco E, et al. A hospital-wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003; 37:180-186.
26. Apisarnthanarak A, Danchaivijitr S, Khawcharoenporn T, et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 2006; 42:768-775.
27. World Health Organization. ATC classification index with DDDs. Oslo, Norway: World Health Organization Collaborating Center for Drug Statistics Methodology, 2001.